Globus Medical (NYSE: GMED) reported Q2 EPS of $1.34, $0.24 better than the analyst estimate of $1.10. Revenue for the quarter came in at $789.61 million versus the consensus estimate of $782.89 million.

FY2026 Outlook-

Revenue between $3.18 billion to $3.22 billion versus the consensus $3.20 billion.

EPS between $4.95 to $5.05 versus the consensus $4.74.

For earnings history and earnings-related data on Globus Medical (GMED) click here.